What were the results of the SYNTAX trial comparing CABG and DES implantation?
The SYNTAX trial randomly assigned 1800 patients to receive DES or CABG. MACE, a composite of death, stroke, MI, or repeat revascularization during the 3 years after randomization, occurred in 20.2% of CABG patients and 28.0% of those undergoing DES implantation (P,0.001).